Literature DB >> 18463192

Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.

Jin Hee Lee1, Shichao Xia, Louis Ragolia.   

Abstract

Diabetes and insulin resistance are associated with an increased risk of hypertension and cardiovascular disease. Recent evidence demonstrates that AT2 receptors (AT2R) play an important role in the hemodynamic control of hypertension by vasodilation. The quantitative significance of AT2R in the establishment of diabetic vascular dysfunction, however, is not well defined and needs further investigation. Goto-Kakizaki (GK) rats, a polygenic model of spontaneous normotensive type 2 diabetes, were used to examine any abnormalities in cardiovascular function associated with AT2R at the early stage of the disease without endothelium influence. Using a myograph to measure the isometric force, we observed that ANG II-induced contraction was impaired in denuded GK aorta compared with control Wistar-Kyoto (WKY) aorta and exhibited a retarded AT1R antagonist response and enhanced Rho kinase signaling. When AT1R were blocked, ANG II induced a significant vasodilation of precontracted GK aorta via AT2R. The protein and mRNA of AT2R were increased in diabetic GK denuded aorta. Blocking AT2R restored the ANG II-induced contraction in the GK vasculature to control levels, demonstrating a counteractive role for AT2R in AT1R-induced contraction. Inhibition of inducible nitric oxide synthase (iNOS) by NG-monomethyl-L-arginine mimicked AT2R inhibition in denuded GK aorta, suggesting that AT2R-induced vasodilation was dependent on iNOS/NO generation. The protein and mRNA of iNOS were also increased in GK aorta. In conclusion, these results clearly demonstrate that enhanced AT2R and iNOS-induced, NO-mediated vasodilation impair ANG II-induced contraction in an endothelium-independent manner at the early stage of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463192      PMCID: PMC2494818          DOI: 10.1152/ajpregu.00191.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  56 in total

1.  Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

2.  Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole.

Authors:  S Arima; Y Endo; H Yaoita; K Omata; S Ogawa; K Tsunoda; M Abe; K Takeuchi; K Abe; S Ito
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

3.  Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.

Authors:  R M Touyz; D Endemann; G He; J S Li; E L Schiffrin
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

Review 4.  The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.

Authors:  Ulf Janssen; Athina Vassiliadou; Stephen G Riley; Aled O Phillips; Jürgen Floege
Journal:  J Nephrol       Date:  2004 Nov-Dec       Impact factor: 3.902

5.  Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta.

Authors:  Sandra Y Fukada; Carlos R Tirapelli; Márcio A F de Godoy; Ana M de Oliveira
Journal:  J Cardiovasc Pharmacol       Date:  2005-02       Impact factor: 3.105

6.  Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.

Authors:  F Folli; C R Kahn; H Hansen; J L Bouchie; E P Feener
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.

Authors:  P Gohlke; C Pees; T Unger
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

Review 8.  Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.

Authors:  M Horiuchi; M Akishita; V J Dzau
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

9.  Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

Authors:  Y Tsutsumi; H Matsubara; H Masaki; H Kurihara; S Murasawa; S Takai; M Miyazaki; Y Nozawa; R Ozono; K Nakagawa; T Miwa; N Kawada; Y Mori; Y Shibasaki; Y Tanaka; S Fujiyama; Y Koyama; A Fujiyama; H Takahashi; T Iwasaka
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

10.  Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration.

Authors:  G M Pieper
Journal:  Diabetologia       Date:  1999-02       Impact factor: 10.122

View more
  15 in total

1.  The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice.

Authors:  Paul C Dolber; Huixia Jin; Rashid Nassar; Thomas M Coffman; Susan B Gurley; Matthew O Fraser
Journal:  Neurourol Urodyn       Date:  2015-01       Impact factor: 2.696

2.  High glucose up-regulates angiotensin II subtype 2 receptors via interferon regulatory factor-1 in proximal tubule epithelial cells.

Authors:  Quaisar Ali; Rifat Sabuhi; Tahir Hussain
Journal:  Mol Cell Biochem       Date:  2010-07-02       Impact factor: 3.396

Review 3.  AT2 receptor signaling and sympathetic regulation.

Authors:  Lie Gao; Irving H Zucker
Journal:  Curr Opin Pharmacol       Date:  2010-12-13       Impact factor: 5.547

4.  Impaired insulin-stimulated myosin phosphatase Rho-interacting protein signaling in diabetic Goto-Kakizaki vascular smooth muscle cells.

Authors:  Jin Hee Lee; Thomas Palaia; Louis Ragolia
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-08       Impact factor: 4.249

5.  Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.

Authors:  Jin Hee Lee; Thomas Palaia; Louis Ragolia
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

6.  Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.

Authors:  Maria Alícia Carrillo-Sepúlveda; Graziela S Ceravolo; Zuleica Bruno Fortes; Maria Helena Carvalho; Rita C Tostes; Francisco R Laurindo; R Clinton Webb; Maria Luiza M Barreto-Chaves
Journal:  Cardiovasc Res       Date:  2009-09-04       Impact factor: 10.787

7.  Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats.

Authors:  Athar H Siddiqui; Quaisar Ali; Tahir Hussain
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

Review 8.  Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.

Authors:  Naureen Fatima; Sanket N Patel; Tahir Hussain
Journal:  Hypertension       Date:  2021-04-12       Impact factor: 10.190

9.  Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases.

Authors:  Eleanor I Ager; Way W Chong; Shu-Wen Wen; Christopher Christophi
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

10.  Emerging role of angiotensin type 2 receptor (AT2R)/Akt/NO pathway in vascular smooth muscle cell in the hyperthyroidism.

Authors:  Maria Alícia Carrillo-Sepúlveda; Graziela S Ceravolo; Cristina R Furstenau; Priscilla de Souza Monteiro; Zuleica Bruno-Fortes; Maria Helena Carvalho; Francisco R Laurindo; Rita C Tostes; R Clinton Webb; Maria Luiza M Barreto-Chaves
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.